228 related articles for article (PubMed ID: 26087398)
1. siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine.
Di Cresce C; Figueredo R; Rytelewski M; Maleki Vareki S; Way C; Ferguson PJ; Vincent MD; Koropatnick J
Oncotarget; 2015 Sep; 6(26):22397-409. PubMed ID: 26087398
[TBL] [Abstract][Full Text] [Related]
2. Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed.
Di Cresce C; Figueredo R; Ferguson PJ; Vincent MD; Koropatnick J
J Pharmacol Exp Ther; 2011 Sep; 338(3):952-63. PubMed ID: 21673071
[TBL] [Abstract][Full Text] [Related]
3. Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC).
Kroep JR; van Moorsel CJ; Veerman G; Voorn DA; Schultz RM; Worzalla JF; Tanzer LR; Merriman RL; Pinedo HM; Peters GJ
Adv Exp Med Biol; 1998; 431():657-60. PubMed ID: 9598147
[No Abstract] [Full Text] [Related]
4. Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2) towards the sugar moiety of nucleosides, including O'-alkyl analogues.
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Nucleosides Nucleotides; 1999 Aug; 18(8):1883-903. PubMed ID: 10478487
[TBL] [Abstract][Full Text] [Related]
5. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ
Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076
[TBL] [Abstract][Full Text] [Related]
6. Expression of human mitochondrial thymidine kinase in Escherichia coli: correlation between the enzymatic activity of pyrimidine nucleoside analogues and their inhibitory effect on bacterial growth.
Wang J; Su C; Neuhard J; Eriksson S
Biochem Pharmacol; 2000 Jun; 59(12):1583-8. PubMed ID: 10799656
[TBL] [Abstract][Full Text] [Related]
7. DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells.
Saiki Y; Yoshino Y; Fujimura H; Manabe T; Kudo Y; Shimada M; Mano N; Nakano T; Lee Y; Shimizu S; Oba S; Fujiwara S; Shimizu H; Chen N; Nezhad ZK; Jin G; Fukushige S; Sunamura M; Ishida M; Motoi F; Egawa S; Unno M; Horii A
Biochem Biophys Res Commun; 2012 Apr; 421(1):98-104. PubMed ID: 22490663
[TBL] [Abstract][Full Text] [Related]
8. 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.
Gröschel B; Kaufmann A; Höver G; Cinatl J; Doerr HW; Noordhuis P; Loves WJ; Peters GJ; Cinatl J
Biochem Pharmacol; 2002 Jul; 64(2):239-46. PubMed ID: 12123744
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies.
Réjiba S; Bigand C; Parmentier C; Hajri A
Neoplasia; 2009 Jul; 11(7):637-50. PubMed ID: 19568409
[TBL] [Abstract][Full Text] [Related]
10. Tissue specific distribution of pyrimidine deoxynucleoside salvage enzymes shed light on the mechanism of mitochondrial DNA depletion.
Wang L; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):400-3. PubMed ID: 20544526
[TBL] [Abstract][Full Text] [Related]
11. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
Bergman AM; Pinedo HM; Jongsma AP; Brouwer M; Ruiz van Haperen VW; Veerman G; Leyva A; Eriksson S; Peters GJ
Biochem Pharmacol; 1999 Feb; 57(4):397-406. PubMed ID: 9933028
[TBL] [Abstract][Full Text] [Related]
12. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues.
Arnér ES; Spasokoukotskaja T; Eriksson S
Biochem Biophys Res Commun; 1992 Oct; 188(2):712-8. PubMed ID: 1359886
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer.
Ohhashi S; Ohuchida K; Mizumoto K; Fujita H; Egami T; Yu J; Toma H; Sadatomi S; Nagai E; Tanaka M
Anticancer Res; 2008; 28(4B):2205-12. PubMed ID: 18751396
[TBL] [Abstract][Full Text] [Related]
15. Deoxycytidine kinase expression underpins response to gemcitabine in bladder cancer.
Kerr M; Scott HE; Groselj B; Stratford MR; Karaszi K; Sharma NL; Kiltie AE
Clin Cancer Res; 2014 Nov; 20(21):5435-45. PubMed ID: 25224279
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.
Beauséjour CM; Gagnon J; Primeau M; Momparler RL
Biochem Biophys Res Commun; 2002 May; 293(5):1478-84. PubMed ID: 12054682
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of mitochondrial thymidine kinase 2 and deoxyguanosine kinase by didanosine: implication for mitochondrial toxicities of anti-HIV nucleoside analogs.
Sun R; Eriksson S; Wang L
Biochem Biophys Res Commun; 2014 Jul; 450(2):1021-6. PubMed ID: 24976398
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression.
Tang K; Zhang Z; Bai Z; Ma X; Guo W; Wang Y
Oncol Rep; 2011 Apr; 25(4):963-70. PubMed ID: 21225236
[TBL] [Abstract][Full Text] [Related]
19. Increased ratio between deoxycytidine kinase and thymidine kinase 2 in CLL lymphocytes compared to normal lymphocytes.
Nielsen SE; Munch-Petersen B; Mejer J
Leuk Res; 1995 Jul; 19(7):443-7. PubMed ID: 7637389
[TBL] [Abstract][Full Text] [Related]
20. Monophosphorylation by deoxycytidine kinase affects apparent cellular uptake of decitabine in HCT116 colon cancer cells.
Ueda K; Masuda A; Fukuda M; Tanaka S; Hosokawa M; Iwakawa S
Drug Metab Pharmacokinet; 2017 Dec; 32(6):301-310. PubMed ID: 29174536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
